Tumor markers are substances that are produced by the body in response to cancer or other certain benign (non-cancerous) conditions. These substances can be found in samples of blood, tumor tissue, urine, stool and other bodily fluids of some cancer patients.
Tumor markers are useful in helping to detect, diagnose and manage some types of cancers. The level of tumor marker present can sometimes reflect the stage (extent) of the disease or the patient’s prognosis (the likely outcome or the course of disease) for some types of cancers. Tumor markers can also be periodically measured during any cancer therapy treatment, where a decrease in level or a return to normal level for the marker’s can indicate that the treatment is working and the cancer is responding positively. These markers are also often measured after a treatment has ended in order to check for recurrence (i.e. the return of cancer).
Many different tumor markers have been characterized extensively and used for many clinical applications. Some are found to be associated with only one type of cancer whereas other can be linked to two or more types of cancers. Presently, there is no “universal” tumor marker which has the ability to detect any type of cancer.
Some of the most common tumor markers and the cancer type that they are used for are listed below:
- Alpha-Fetoprotein (AFP): Liver cancer and germ cell tumor.
- Beta-2-Microglobulin (B2M): Multiple myeloma, some lymphomas and chronic lymphocytic leukemia.
- Beta-Chorionic Gonadotropin (Beta-CG): Choriocarcinoma and germ cell tumors.
- BRCA1 and BRCA2: Ovarian cancer.
- C-Kit/CD117: Mucosal melanoma and gastrointestinal stromal tumor.
- Calcitonin: Medullary thyroid cancer.
- CA15-3/CA27.29: Breast cancer.
- CA19-9: Bile duct cancer, pancreatic cancer, gastric cancer and gallbladder cancer.
- CA-125: Ovarian cancer.
- Carcinoembryonic antigen (CEA): Colorectal cancer.
- Chromogranin A (CgA): Neuroendocrine tumors.
- Cytokeratin fragment 21-1: Lung cancer.
- EGFR: Non-small cell lung cancer.
- Progesterone Receptor (PR)/Estrogen Receptor (ER): Breast cancer.
- Fibrin/Fibrinogen: Bladder cancer.
- Neuron-specific enolase (NSE): Neuroblastoma and small cell lung cancer.
- Prostate-specific antigen (PSA): Prostate cancer.
- Thyroglobulin: Thyroid cancer.
We offers a broad portfolio of tumor markers that can be used for routine diagnostics, clinical research and therapy follow up.
Most Popular Tumor Marker ELISA Kits
- Alpha-Fetoprotein (AFP) ELISA Kit
- Calcitonin ELISA Kit
- Carcinoembryonic Antigen (CEA) ELISA Kit
- Beta-2-microglobulin (B2M) ELISA Kit
- Neuron-Specific Enolase (NSE) ELISA Kit
- Total Prostate Specific Antigen (Total PSA) ELISA Kit
- Carcinoma Antigen CA-125 (CA-125) ELISA Kit
- Cytokeratin fragment 21-1 (Cyfra 21-1) ELISA Kit
- Chromogranin A ELISA Kit